Nova Eye USA Sales Growth Opportunity
Recent Developments in USA Reimbursement
Five MACS table draft local coverage
determinations¹. (LCD) proposing
changes to reimbursement for
minimally invasive glaucoma
surgeries (MIGS).
On 31 October 2023 WPS issued
a "final" LCD and on 9 November
the other 4 MACS did the same.
They are required to give 45 days'
notice, making the effective date
23 December 2023.
On 8 December
2023 the effective
date of the LCDs
was shifted to 29
January 2024.
يع
July 2023
Aug 2023
Sep 2023
Oct 2023
Nov 2023
Dec 2023
Jan 2024
An LCD is a determination
made on coverage made that
applies to the region for which
the MAC is responsible.
Among other changes, the final LCDs designated canaloplasty as
"investigational" and would not be reimbursed.
Nova Eye immediately activated near-term initiatives designed to
overcome the challenges imposed by the proposed LCD changes to
reduce the expected impact on sales revenue and provided support
to doctors and professional bodies to lobby against the changes.
On 29 December 2023,
the LCDs were
withdrawn and
reimbursement for
canaloplasty to continue
unchanged.
1. In 2020, by Palmetto, issued a draft LCD and it was eventually with drawn without making it the "final".
nova-eye.com | 30View entire presentation